Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel® in mice

INTRODUCTION: Malaria transmission blocking vaccines (TBV) are innovative approaches that aim to induce immunity in humans against Plasmodium during mosquito stage, neutralizing the capacity of the infected vectors to transmit malaria. Pfs230D1-EPA/Alhydrogel®, a promising protein-protein conjugate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Autores principales: Coelho, Camila H., Gazzinelli-Guimaraes, Pedro Henrique, Howard, Jennifer, Barnafo, Emma, Alani, Nada A.H., Muratova, Olga, McCormack, Ashley, Kelnhofer, Emily, Urban, Joseph F., Narum, David L., Anderson, Charles, Langhorne, Jean, Nutman, Thomas B., Duffy, Patrick E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6382667/
https://ncbi.nlm.nih.gov/pubmed/30685251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.01.027
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares